Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.
Florian LipsmeierKirsten I TaylorTimothy KilchenmannDetlef WolfAlf ScotlandJens Schjodt-EriksenWei-Yi ChengIgnacio Fernandez-GarciaJuliane Siebourg-PolsterLiping JinJay SotoLynne VerselisFrank BoessMartin KollerMichael GrundmanAndreas U MonschRonald B PostumaAnirvan GhoshThomas KremerChristian CzechChristian GossensMichael LindemannPublished in: Movement disorders : official journal of the Movement Disorder Society (2018)
These findings demonstrate the feasibility of smartphone-based digital biomarkers and indicate that smartphone-sensor technologies provide reliable, valid, clinically meaningful, and highly sensitive phenotypic data in Parkinson's disease. © 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.